Indian Mycophenolate Exporters: Complete Supplier Ranking with Market Share — 512 Manufacturers (2026) — TransData Nexus

Q: Who is the largest mycophenolate buyer importing from India?

EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) is the largest mycophenolate importer from India with a 51.1% market share and import value of $170.9M.

Q: How many mycophenolate buyers import from India?

There are 512 active mycophenolate buyers importing from India, with a combined import market of $334.4M across 2,529 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top mycophenolate buyers from India?

The top 5 mycophenolate buyers — EVERSANA LIFE SCIENCES SERVICES,LLC, STRIDES PHARMA INC,, STRIDES PHARMA INC, APOTEX PTY LTD, ASCEND LABORATORIES,LLC — together control 66.8% of total mycophenolate import value from India.

Suresh Sormare

Mycophenolate

India Pharmaceutical Trade Intelligence

$334.4M167 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES76.6%India → AUSTRALIA6.1%

ImportsGERMANY → India$999.6M ITALY → India$223.6M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $256.2M through 596 shipments. This represents a market share of 76.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• EVERSANA LIFE SCIENCES SERVICES,LLC - $170.9M (66.7% of country's total business)

• STRIDES PHARMA INC, - $13.9M (5.4% of country's total business)

• STRIDES PHARMA INC - $13.8M (5.4% of country's total business)

• ASCEND LABORATORIES,LLC - $12.1M (4.7% of country's total business)

• SANDOZ INC. C/O EXEL, INC. - $10.7M (4.2% of country's total business)

• Rest of United States's importers - $34.8M (13.6% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $429.8K, indicating premium pricing strategy compared to the market average of $132.2K.

United States is a key market for Mycophenolate imports, representing 76.6% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Mycophenolate buyer market intelligence

1Buyer Segment Analysis

Our data indicates that Mycophenolate exports from India amounted to $334.4 million across 2,529 shipments, involving 167 exporters and 512 buyers spanning 100 importing countries. The repeat buyer rate stands at 53.7%, suggesting a stable demand base.

Distributors: Entities such as EVERSANA LIFE SCIENCES SERVICES, LLC, which accounted for $170.93 million in imports to the United States, fall into this category. Distributors typically purchase large volumes to supply various healthcare providers, including hospitals and pharmacies. Their buying behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.

Contract Manufacturers: Companies like STRIDES PHARMA INC., importing $13.86 million worth of Mycophenolate to the United States, are indicative of contract manufacturing operations. These firms procure active pharmaceutical ingredients (APIs) or finished products to produce generic formulations under their brand names. Their purchasing patterns often involve substantial quantities aligned with production schedules and market demand forecasts.

Government Procurement: While specific entities such as UNICEF or national health services are not listed among the top buyers in our data, government procurement agencies in various countries engage in tender-based purchasing to supply public healthcare facilities. These agencies prioritize cost-effectiveness and compliance with regulatory standards, often resulting in large, periodic orders.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Mycophenolate buyer market intelligence

1Country-Specific Import Regulations

United States:

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Mycophenolate is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs or a New Drug Application (NDA) for new formulations. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.

3. Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though this can vary based on the completeness of the application and any required amendments.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

Australia:

1. Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process: Mycophenolate must be listed in the Australian Register of Therapeutic Goods (ARTG). Importers are required to submit a dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The TGA's evaluation process can take approximately 12 months, depending on the complexity of the application and the need for additional information.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Australia.

United Kingdom:

1. Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).

2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from the MHRA, which requires submission of comprehensive data on the product's quality, safety, and efficacy.

Demand Drivers & Market Opportunity

TransData Nexus Mycophenolate buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Mycophenolate in importing countries is primarily driven by its critical role in preventing organ transplant rejection and treating certain autoimmune diseases. The inclusion of Mycophenolate on the World Health Organization's Model List of Essential Medicines underscores its importance in global health. This designation encourages countries to prioritize its availability within their healthcare systems.

Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries incorporate Mycophenolate into their national formularies, facilitating procurement through tender-based purchasing mechanisms. The presence of 512 buyers across 100 countries, as per our data, reflects a widespread and sustained demand, presenting significant market opportunities for suppliers.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Mycophenolate Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest mycophenolate buyer importing from India?

Based on import volume and value, EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) leads with $170.9M in imports and a 51.1% market share — the highest of any single mycophenolate importer. STRIDES PHARMA INC, (UNITED STATES) and STRIDES PHARMA INC (UNITED STATES) are the next largest buyers.

QHow many companies buy mycophenolate from India?

There are 512 active mycophenolate buyers importing from India, with a combined market of $334.4M across 2,529 shipments to 100 countries. The top 5 buyers hold 66.8% of total import value, while the remaining 507 buyers handle the other 33.2%.

QWhich countries import the most mycophenolate from India?

The top importing countries for mycophenolate from India are United States (76.6%), Australia (6.1%), United Kingdom (3.9%), Italy (1.3%), Brazil (1.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of mycophenolate, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for mycophenolate from India?

The average import transaction value for mycophenolate from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Mycophenolate buyer market intelligence

1Buyer Segment Analysis

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Mycophenolate buyer market intelligence

1Country-Specific Import Regulations

United States:

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though this can vary based on the completeness of the application and any required amendments.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

Australia:

1. Regulatory Authority: Therapeutic Goods Administration (TGA).

3. Estimated Timeline for Registration: The TGA's evaluation process can take approximately 12 months, depending on the complexity of the application and the need for additional information.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Australia.

United Kingdom:

1. Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).

2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from the MHRA, which requires submission of comprehensive data on the product's quality, safety, and efficacy.

Demand Drivers & Market Opportunity

TransData Nexus Mycophenolate buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mycophenolate

Mycophenolate

Who Buys Mycophenolate from India — 512 Importers Behind a $334.4M Market

Top Mycophenolate Importers — Ranked by Import Value

Top Mycophenolate Buyers & Importers

Related Analysis

Need Details?

Mycophenolate — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Mycophenolate — and from which countries?

Mycophenolate — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Mycophenolate Buyers & Importers

QWho is the largest mycophenolate buyer importing from India?

QHow many companies buy mycophenolate from India?

QWhich countries import the most mycophenolate from India?

QWhat is the average import order value for mycophenolate from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Australia

3United Kingdom

4Italy

5Brazil

Analysis Methodology